Torrent Pharmaceuticals (TORNTPHARM) Share Price Falls 2.28% Today; Stock News, Valuation and Peer Context
- August 31, 2026
- Posted by: Harsh Piplani
- Category: News
Torrent Pharmaceuticals Share Price declined to Rs 4,920 on 31 August 2026, down 2.28% from the previous close, while market capitalisation stood at Rs 1,91,515.22 Cr. The move places Torrent Pharmaceuticals in focus for Torrent Pharmaceuticals Stock News and Torrent Pharmaceuticals Share Price Today searches. The supplied data confirms a same-day share price fall, but it does not establish a company-specific catalyst. What can be verified is the day’s price action, the company’s Large Cap profile, and a valuation that sits well above the benchmark range in its industry. For readers following Torrent Pharmaceuticals Share Price Live on Univest, today’s decline is best read as a price event that now needs to be viewed alongside fundamentals, sector context and peer comparison.
Torrent Pharmaceuticals (TORNTPHARM) Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 4,920 |
| Previous Close | Rs 5,035 |
| Today's Move | -Rs 115.00 (-2.28%) |
| Open | Rs 5,049 |
| High | Rs 5,049 |
| Low | Rs 4,918.2 |
| Turnover | Rs 1.72 crore |
| Market Capitalisation | Rs 1,91,515.22 crore |
| Market Cap Category | Large Cap |
Torrent Pharmaceuticals Share Price Today shows a clear intraday decline from the opening level to the close. The stock opened at Rs 5,049, matched its day high at Rs 5,049, and later touched a day low of Rs 4,918.2 before ending at Rs 4,920. That means the share price fall from the previous close of Rs 5,035 was Rs 115, or 2.28% for the session. The stock’s market-cap category is Large Cap, and the company’s market capitalisation is Rs 1,91,515.22 Cr. Turnover stood at Rs 1.72 Cr. In plain terms, Torrent Pharmaceuticals Stock News today is about a fall in price rather than any verified change in company disclosures. The available data confirms the decline, the close below the previous session’s level, and the narrow gap between the day’s low and closing price. For investors tracking Torrent Pharmaceuticals Share Price Update on Univest, the next step is to connect this price action with fundamentals and sector comparison.
Torrent Pharmaceuticals (TORNTPHARM) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 1,91,515.22 crore |
| P/E Ratio | 87.81x |
| P/B Ratio | 21.34x |
| ROE | 26.76% |
| ROCE | 19.27% |
| EPS | Rs 57.34 |
| Book Value Per Share | Rs 235.97 |
| Dividend Yield | 0.75% |
Torrent Pharmaceuticals Share Price sits alongside a rich fundamental profile. The company’s market capitalisation is Rs 1,91,515.22 Cr and enterprise value is not supplied in the dataset, so the verified valuation focus remains on the numbers that are provided: P/E of 87.81, P/B of 21.34, EPS of Rs 57.34, book value of Rs 235.97 and dividend yield of 0.75%. These figures show a stock that is priced far above the median valuation seen in its industry benchmark, which is important context for Torrent Pharmaceuticals Share News. ROE stands at 26.76% and ROCE at 19.27%, both comfortably higher than the industry medians in the supplied comparison set. That combination of high valuation and strong return ratios is central to Torrent Pharmaceuticals Stock Analysis today. For Torrent Pharmaceuticals Share Price, the question is not simply the day’s fall; it is how the market is pricing earnings, equity and capital employed relative to peers and the wider Pharmaceuticals & Drugs universe. Univest tracks these ratios so readers can place price moves in a wider financial framework.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 87.81x |
| Benchmark Median P/E | 31.21x |
| Benchmark Average P/E | 48.1x |
| Benchmark P/E Range | 3.7x to 672.45x |
| Company P/B Ratio | 21.34x |
| Benchmark Median P/B | 2.88x |
| Benchmark Average P/B | 4.19x |
| Company ROE | 26.76% |
| Benchmark Median ROE | 11.78% |
| Benchmark Average ROE | 10.68% |
| Company ROCE | 19.27% |
| Benchmark Median ROCE | 13.6% |
| Benchmark Average ROCE | 13.27% |
| Company Market Capitalisation | Rs 1,91,515.22 crore |
| Benchmark Median Market Cap | Rs 670.73 crore |
| Benchmark Average Market Cap | Rs 14,040.53 crore |
Torrent Pharmaceuticals operates in Healthcare and the Pharmaceuticals & Drugs industry, where the supplied benchmark scope covers 203 companies in the same industry. Against that backdrop, Torrent Pharmaceuticals Share Price trades at a P/E of 87.81 versus the industry median of 31.21 and average of 48.1. Its P/B of 21.34 is also well above the industry median of 2.88 and average of 4.19. On profitability, ROE of 26.76% is above the industry median of 11.78% and average of 10.68%, while ROCE of 19.27% is also above the median of 13.6% and average of 13.27%. The benchmark market-cap median is Rs 670.73 Cr, with an average of Rs 14,040.53 Cr, which places Torrent Pharmaceuticals Share Price within a very large-company context. This sector view matters because today’s move should be read alongside valuation rather than as an isolated event. Univest’s sector lens helps readers compare stock price movement with the broader industry benchmark and sector performance.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | SUNPHARMA | 4,60,696.31 | 38.09 | 5.33 | 14.85 | 19.11 |
| Divi's Laboratories | DIVISLAB | 2,46,062.83 | 84.12 | 13.93 | 16.19 | 21.51 |
| Zydus Lifesciences | ZYDUSLIFE | 1,18,403.7 | 26.24 | 4.39 | 19.69 | 21.39 |
| Cipla | CIPLA | 1,14,554.33 | 33.99 | 3.26 | 11.83 | 16 |
| Laurus Labs | LAURUSLABS | 1,04,566.62 | 95.64 | 18.54 | 18.31 | 18.2 |
Among the supplied peers, Torrent Pharmaceuticals Share Price stands out for scale and valuation. Its market capitalisation of Rs 1,91,515.22 Cr is below Sun Pharmaceutical Industries at Rs 4,60,696.31 Cr and Divi’s Laboratories at Rs 2,46,062.83 Cr, but well above Zydus Lifesciences, Cipla and Laurus Labs In valuation terms, Torrent Pharmaceuticals’ P/E of 87.81 is higher than Sun Pharmaceutical’s 38.09, Zydus Lifesciences’ 26.24 and Cipla’s 33.99, and lower than Laurus Labs’ 95.64 and Divi’s Laboratories’ 84.12. ROE at 26.76% is stronger than most peers listed here, while ROCE at 19.27% is ahead of Sun Pharmaceutical, Cipla and Laurus Labs, but slightly behind Divi’s Laboratories, Zydus Lifesciences and Lupin in the broader peer set. For Torrent Pharmaceuticals Share Price News, the peer lens shows a premium valuation supported by solid return ratios.
Why Investors Are Watching Torrent Pharmaceuticals
- Torrent Pharmaceuticals Share Price fell 2.28% today to Rs 4,920 from Rs 5,035.
- The stock moved between Rs 5,049 and Rs 4,918.2 during the session.
- Market capitalisation stood at Rs 1,91,515.22 Cr and the market-cap category is Large Cap.
- P/E of 87.81 and P/B of 21.34 remain above the industry benchmark medians.
- ROE of 26.76% and ROCE of 19.27% are higher than the industry medians in the supplied benchmark.
About Torrent Pharmaceuticals
Torrent Pharmaceuticals operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The verified data in this article supports a company overview based on those classifications, along with the market-cap context of a Large Cap company and a current market capitalisation of Rs 1,91,515.22 Cr. Torrent Pharmaceuticals Share Price remains a closely tracked market topic because it sits within a large, benchmarked pharmaceutical universe and is compared here against peers and the wider industry set. For Univest readers, that makes Torrent Pharmaceuticals Stock News useful not only for the day’s move, but also for placing the company inside its sector context.
Track Torrent Pharmaceuticals Share Price on Univest
Use Torrent Pharmaceuticals (TORNTPHARM) live share-price page,Univest top decliners screener,Univest market blogs to review live stock data, top decliners and related market analysis.
You can track Torrent Pharmaceuticals Share Price on Univest for live updates, company fundamentals, shareholding pattern, market capitalisation, 52-week levels and broader market insights. Univest also helps readers compare Torrent Pharmaceuticals Stock News with sector context and peer valuation in one place.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why did Torrent Pharmaceuticals Share Price fall today?
Ans. The supplied data confirms that Torrent Pharmaceuticals Share Price fell 2.28% today, but it does not establish a company-specific catalyst. The verified facts are the price move, the day’s range and the close at Rs 4,920.
What is Torrent Pharmaceuticals Share Price today?
Ans. Torrent Pharmaceuticals Share Price today closed at Rs 4,920, down Rs 115 from the previous close of Rs 5,035. The day’s move was 2.28%, with an opening price of Rs 5,049.
What is Torrent Pharmaceuticals market capitalisation?
Ans. Torrent Pharmaceuticals has a market capitalisation of Rs 1,91,515.22 Cr. The company is classified as a Large Cap in the supplied data, which provides useful context for its stock price movement today.
How expensive is Torrent Pharmaceuticals Share Price versus the industry?
Ans. Torrent Pharmaceuticals Share Price trades at a P/E of 87.81 and P/B of 21.34, both above the industry median and average in the supplied benchmark set. That makes valuation a key part of today’s stock news.
How do Torrent Pharmaceuticals return ratios compare with the industry?
Ans. Torrent Pharmaceuticals reports ROE of 26.76% and ROCE of 19.27%. Both are above the industry medians in the supplied benchmark, so the fundamentals add context even after today’s share price fall.
How does Torrent Pharmaceuticals compare with peers?
Ans. Torrent Pharmaceuticals Share Price is supported by a large market cap and return ratios that compare well with several peers. Its P/E is higher than Sun Pharma and Zydus, but lower than Laurus Labs.
What is Torrent Pharmaceuticals EPS and book value?
Ans. Torrent Pharmaceuticals has EPS of Rs 57.34 and book value of Rs 235.97. EPS shows earnings attributable to each share, while book value indicates the accounting net worth behind each share.
Does Torrent Pharmaceuticals pay a dividend?
Ans. Yes, the supplied dividend yield is 0.75%. Dividend yield reflects the historical payout relative to the current share price, so it is one more metric used in Torrent Pharmaceuticals Share Price analysis.
